This model is intriguing because FXYD2 is the only β-cell differentially expressed gene in T2D that has been convincingly replicated across multiple scRNA-seq studies, regardless of the choice of platform and analytic tools57. The gene discussed is FXYD2; the disease is type 2 diabetes mellitus.